ESR1 and breast cancer: BRCA1/BRCA2 gene mutations account for 16-25% of FBC cases and 5% of BC-related gene mutations [25, 21] with BRCA1-linked tumors lacking ER expression and BRCA2-linked tumors showing ER positivity [22].